Taro Pharmaceuticals U.S.A., Inc. is recalling 16,944 tubes of Fluocinonide Gel USP (0.05%), a prescription topical medication used for skin conditions. This recall was initiated because traces of Dapsone, a different medication, were found in the finished product due to cross-contamination during manufacturing. Consumers who have this specific 15 gram tube should contact their healthcare provider or pharmacist for guidance and to arrange for a refund.
The presence of trace amounts of Dapsone in a product not intended to contain it poses a risk of unexpected side effects or allergic reactions for users sensitive to Dapsone.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.